The trajectory of Viagra presents a challenging picture for shareholders. While the initial release generated significant returns, the end of its intellectual property protection opened the floodgates to off-brand https://jadaeprk337239.myparisblog.com/42356577/the-copyright-and-pharma-a-precarious-investment